These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32472749)

  • 41. Differential impact of age on survival in head and neck cancer according to classic Cox regression and decision tree analysis.
    Yang CC; Su YC; Lin YW; Huang CI; Lee CC
    Clin Otolaryngol; 2019 May; 44(3):244-253. PubMed ID: 30578588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel classification system for perineural invasion in noncutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes.
    Miller ME; Palla B; Chen Q; Elashoff DA; Abemayor E; St John MA; Lai CK
    Am J Otolaryngol; 2012; 33(2):212-5. PubMed ID: 22177613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 44. Prognostic impact of pathological complete remission after preoperative irradiation in patients with locally advanced head and neck squamous cell carcinoma: re-analysis of a phase 3 clinical study.
    Wang K; Yi J; Huang X; Qu Y; Luo J; Xiao J; Zhang S; Tang Y; Liu W; Xu G; Gao L; Xu Z; Liu S; Wang X
    Radiat Oncol; 2019 Dec; 14(1):225. PubMed ID: 31831042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of surgical resection on survival in patients with advanced head and neck cancer involving the carotid artery.
    Manzoor NF; Russell JO; Bricker A; Koyfman S; Scharpf J; Burkey B; Khan MJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1219-25. PubMed ID: 24077023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis.
    Zhu Y; Liu H; Xie N; Liu X; Huang H; Wang C; Hou J
    Head Neck; 2019 Feb; 41(2):542-550. PubMed ID: 30549142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma.
    Kobayashi K; Yoshimoto S; Matsumoto F; Ando M; Murakami N; Omura G; Fukasawa M; Matsumoto Y; Matsumura S; Akamatsu M; Hiraoka N; Eigitsu R; Mori T
    Ann Surg Oncol; 2019 Jul; 26(7):2294-2303. PubMed ID: 30900104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age is not a predictor of prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Smith JA; Virk S; Palme CE; Low TH; Ch'ng S; Gupta R; Gao K; Clark J
    ANZ J Surg; 2018 Apr; 88(4):E273-E277. PubMed ID: 29611361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes for patients with second primary malignancy after primary surgical treatment for early-stage squamous cell carcinoma of the oral cavity.
    Suton P; Prpic M; Tarle M; Mamic M; Nikles I; Luksic I
    Head Neck; 2018 Nov; 40(11):2347-2352. PubMed ID: 30302872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
    Hung YH; Liu SA; Wang CC; Wang CP; Jiang RS; Wu SH
    PLoS One; 2018; 13(10):e0205365. PubMed ID: 30335795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. pN status predicts outcomes in surgically treated pT1-pT2 patients of various disease stages with squamous cell carcinoma of the head and neck: a 17-year retrospective single center cohort study.
    Qian X; Sinikovic B; Schreiber F; Ochsenreither S; Klinghammer K; Wollenberg B; Kaufmann AM; Albers AE
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2787-2795. PubMed ID: 30159726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
    Chandrasekara S; Davis S; Thomson P; Haydon A
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort.
    Zhong J; Sundersingh M; Dyker K; Currie S; Vaidyanathan S; Prestwich R; Scarsbrook A
    Sci Rep; 2020 Mar; 10(1):4086. PubMed ID: 32139722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
    Eytan DF; Blackford AL; Eisele DW; Fakhry C
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
    Mohamed A; Twardy B; Zordok MA; Ashraf K; Alkhoder A; Schrapp K; Steuer C; Chen Z; Pakkala S; Pillai R; Trad Wadsworth J; Higgins K; Beitler JJ; Ramalingam SS; Owonikoko TK; Khuri FR; Shin DM; Behera M; Saba NF
    Head Neck; 2019 May; 41(5):1490-1498. PubMed ID: 30835900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy.
    Cordes N; Ney M; Beleites T; Aust D; Baretton G; Thames H; Baumann M; Krause M; Löck S; Appold S
    PLoS One; 2018; 13(12):e0209479. PubMed ID: 30571736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review.
    Ghanizada M; Jakobsen KK; Grønhøj C; von Buchwald C
    Oral Oncol; 2019 Mar; 90():67-73. PubMed ID: 30846179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
    Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
    PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration.
    Wang Y; Yang R; Zhao M; Guo W; Zhang L; Zhang W; Wang X
    World J Surg Oncol; 2020 May; 18(1):90. PubMed ID: 32375789
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.